Literature DB >> 30143513

Acupuncture at ST36 exerts neuroprotective effects via inhibition of reactive astrogliosis in infantile rats with hydrocephalus.

Jacqueline Atsuko Tida1, Carlos Henrique Rocha Catalão2,3, Camila Araújo Bernardino Garcia1, Antônio Carlos Dos Santos4, Carlos Ernesto Garrido Salmon5, Luiza da Silva Lopes1.   

Abstract

BACKGROUND: Acupuncture has been associated with improved cerebral circulation, analgesia, neuromodulatory function and neurogenesis. In particular, acupuncture at ST36 has been widely used in several central nervous system (CNS) disorders, including neurodegenerative diseases. However, its effects on hydrocephalus have not been studied. Our aim was to evaluate the effects of acupuncture at ST36 on behaviour, motor development and reactive astrogliosis in infantile rats with hydrocephalus.
METHODS: Hydrocephalus was induced in sixteen 7-day-old pup rats by injection of 20% kaolin into the cisterna magna. One day after hydrocephalus induction, acupuncture was applied once daily (for 30 min) for a total of 21 days in eight randomly selected animals (HAc group) while the remaining eight remained untreated (H group). An additional eight healthy animals were included as controls (C group). All animals were weighed daily and, from the fifth day after hydrocephalus induction, underwent MRI to determine the ventricular ratio (VR). Rats were also exposed to modified open-field tests every 3 days until the end of the experiment. After 21 days all the animals were euthanased and their brains removed for histology and immunohistochemistry.
RESULTS: Hydrocephalic rats showed an increase in VR when compared with control rats (P<0.01). In addition, these animals exhibited delayed weight gain, which was attenuated with acupuncture treatment. Hydrocephalic animals treated with acupuncture performed better in open field tests (P<0.05), and had a reduction in reactive astrocyte cell density in the corpus callosum and external capsule, as assessed by GFAP (glial fibrillary acidic protein) immunohistochemistry (P<0.05).
CONCLUSIONS: These findings indicate that acupuncture at ST36 has a neuroprotective potential mediated, in part, by inhibition of astrogliosis. © Author(s) (or their employer(s)) 2018. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  acupuncture

Mesh:

Substances:

Year:  2018        PMID: 30143513     DOI: 10.1136/acupmed-2017-011515

Source DB:  PubMed          Journal:  Acupunct Med        ISSN: 0964-5284            Impact factor:   2.267


  5 in total

1.  Effects of Transcutaneous Electrical Acupoint Stimulation on Postoperative Cognitive Decline in Elderly Patients: A Pilot Study.

Authors:  Tianlin Liu; Chunping Yin; Yanan Li; Fang Gao; Lili Yu; Zhigang Wang; Qiujun Wang
Journal:  Clin Interv Aging       Date:  2021-05-03       Impact factor: 4.458

Review 2.  Diagnosis and treatment for normal pressure hydrocephalus: From biomarkers identification to outcome improvement with combination therapy.

Authors:  Pao-Hui Tseng; Li-Kung Wu; Yi-Cheng Wang; Tsung-Jung Ho; Shinn-Zong Lin; Sheng-Tzung Tsai
Journal:  Tzu Chi Med J       Date:  2021-04-19

Review 3.  Mechanism Underlying Acupuncture Therapy in Spinal Cord Injury: A Narrative Overview of Preclinical Studies.

Authors:  Kunpeng Jiang; Yulin Sun; Xinle Chen
Journal:  Front Pharmacol       Date:  2022-04-07       Impact factor: 5.988

4.  Brain Activities Responding to Acupuncture at ST36 (zusanli) in Healthy Subjects: A Systematic Review and Meta-Analysis of Task-Based fMRI Studies.

Authors:  Haoming Huang; Xiaomei Yue; Xi Huang; Wenjie Long; Shangyu Kang; Yawen Rao; Jingchun Zeng; Junling Zuo; Lin Wang; Hongjuan Li; Yeqing Wang; Shijun Qiu; Weixuan Zhao
Journal:  Front Neurol       Date:  2022-07-22       Impact factor: 4.086

Review 5.  AQP4, Astrogenesis, and Hydrocephalus: A New Neurological Perspective.

Authors:  Leandro Castañeyra-Ruiz; Ibrahim González-Marrero; Luis G Hernández-Abad; Seunghyun Lee; Agustín Castañeyra-Perdomo; Michael Muhonen
Journal:  Int J Mol Sci       Date:  2022-09-09       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.